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In two-dimensional tryptic phosphopeptide mapping, the ,%subunit of the insulin receptor phosphorylated by 12-O-tetra- 
decanoylphorbol-13-acetate in rat hepatoma cells (H-35) was separated into one phosphothreonine-containing peptide 
and several phosphoserine-containing peptides. The synthetic peptide coding residues 1327-1343 in the C-terminal region 
of the rat insulin receptor was phosphorylated at the threonine residue by protein kinase C in a phosphatidylserine and 
oleoylacetylglycerol dependent manner. Tryptic digest of this phosphopeptide migrated to the same position as the phos- 
phothreonine containing peptide obtained from the /?-subunit in two-dimensional phosphopeptide mapping. These data 
suggested that Thr 1336 of the insulin receptor is the site of phosphorylation by protein kinase C in intact cells. 
Insulin receptor; Protein kinase C; Phosphopeptide mapping, two-dimensional; Phosphothreonine 
1. INTRODUCTION 
Insulin causes the phosphorylation of tyrosine 
residues and increases the phosphorylation of 
serine and threonine residues of its own receptor in 
an intact cell [l]. Several phosphorylation sites 
were identified as tyrosine residues 1146 (number- 
ing of amino acids in this paper conforms to that of 
Ullrich et al. [15]), 1150 and 1151 [2,3]. Tyrosine- 
phosphorylation of these residues correlates closely 
with the activation of the insulin receptor-kinase 
[3,4]. Tyrosine residues at 13 16 and 1322 were also 
reported to be phosphorylated [2,3]. 12-O-tetra- 
decanoylphorbol-13-acetate (TPA) increased the 
phosphorylation of the insulin receptor at serine 
and threonine residues [5,6]. At the same time, 
TPA inhibited several insulin effects in intact cell 
[6]. However, none of the serine- or threonine- 
phosphorylation sites stimulated by TPA were 
identified. We show here that TPA stimulates the 
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phosphorylation of threonine residue 1336 in the 
human sequence of the &subunit of the insulin 
receptor in rat hepatoma cell (H-35). 
2. MATERIALS AND METHODS 
2.1. Materials 
The synthetic peptide Gly-Gly-Lys-Lys-Asn-Gly-Arg-Val- 
Leu-Thr-Leu-Pro-Arg-Ser-Asn-Pro-Ser which codes the 
carboxy-terminal 17 amino acids of the rat insulin receptor 
(Lewis, R.E. et al., personal communication) was synthesized 
by Senshu Biosystems (Tokyo). Autoantibodies to the insulin 
receptor (B-5 and B-10) were kindly provided by Drs C.R. Kahn 
(Boston) and S.I. Taylor (Bethesda). Other reagents were pur- 
chased from the same sources as described [7] or were of the best 
commercially available grade. 
2.2. Labeling of the insulin receptor with f’P]orthophosphote 
Rat hepatoma H-35 cells were phosphorylated, solubilized 
and immunoprecipitated [7]. Immunoprecipitation of the eluate 
from wheat germ agglutinin-agarose with anti-insulin receptor 
antibodies was followed by SDS-PAGE as in [7]. Treatment of 
the cell with 1.6 PM TPA was conducted at 37°C for 30 min. 
2.3. Trypticphosphopeptide mopping and phosphoomino acid 
analysis 
The dried polyacrylamide gel containing “P-labeled insulin 
receptor,&subunits was cut out, washed and digested sufficient- 
22 
Published by ELFevier Science Publishers B. V. (Biomedical Divkion) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 
Volume 254, number 1,2 FEBS LETTERS August 1989 
ly with TPCK-trypsin. The digested peptides were analyzed by 
two-dimensional phosphopeptide mapping [8]. The phospho- 
ammo acid analysis of phosphopeptides was carried out with 
one-dimensional (pH 3.5) or two-dimensional (pH 1.9 and pH 
3 5) thin-layer cellulose electrophoreses [9]. 
2.4. Phosphorylation of synthetic peptides of rat insulin 
receptor by protein kinase C 
Synthetic peptide (0.1 mg) and protein kinase C purified from 
rat brain as described by House et al. [lo] were incubated in 
60 yl of 56 mM Tris-Cl buffer (pH 7.4) containing 1 mM DTT, 
0.5 mM EDTA, 1.5 mM CaCl2, 3 mM MgClr, 10pM [r-“PI- 
ATP (5 &i) with or without 4 pg/ml phosphatidylserine (PtS) 
and 33 pg/ml 1-oleoyl-2-acetylglycerol (OAG) at 25°C for 
10 min. The reaction was terminated by addition of bovine 
serum albumin and trichloroacetic acid solutions. The superna- 
tant after centrifugation was poured onto phosphocellulose 
paper. The radioactivity of the paper was measured by 
Cerenkov counting after washing and drying. The phosphopep- 
tide on the paper was directly digested by TPCK-trypsin as 
above and purified on a Waters SepPak column [ll]. Peptide 
mapping and phosphoamino acid analysis of the phosphopep- 
tide were carried out as above. 
3. RESULTS AND DISCUSSION 
The ,&subunit of the H-35 rat hepatoma insulin 
receptor is phosphoprotein. By two-dimensional 
phosphopeptide mapping, several spots of tryptic 
phosphopeptides were identified. The assignments 
and results on the main and clear spots from two- 
dimensional peptide mapping are shown in fig. 1A. 
The results of phosphoamino acid analysis of these 
spots are shown in fig.lB. Two phosphoserine- 
containing peptides (spots b,d) and one weak phos- 
phothreonine-containing peptide (spot a) were 
clearly identified in the ,&subunit of the insulin 
receptor without stimulation. Additionally, spot c 
was identified as Pi. 
Treatment of H-35 rat hepatoma cell with 
1.6 PM TPA for 30 min increased phosphorylation 
of the insulin receptor &subunit insulin receptor 
about 2-fold. In two-dimensional phosphopeptide 
maps, TPA mainly increased the phosphorylation 
of the tryptic phosphopeptides designated as spots 
a, b and d (fig.lA). 
Goren et al. [12] demonstrated that mild trypsin 
digestion (10 pg/ml, for l-10 min at 22°C) of the 
wheat germ agglutinin-purified insulin receptor 
resulted in the loss of the &subunit C-terminal 
region containing residues 13 16 and 1322. We con- 
firmed that the mildly trypsinized P-subunit 
(85 kDa) of the insulin receptor obtained from 
insulin-treated H-35 cells was immunoprecipitated 
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Fig.1. Two-dimensional peptide map of the TPA-stimulated 
H-35 cell insulin receptor b-subunit and phosphoamino acid 
identification of its phosphopeptides. (A) Two-dimensional 
peptide map of the insulin receptor b-subunit obtained from un- 
treated (1) or TPA-stimulated (2) H-35 cells. (B) Phosphoamino 
acid analysis of spots a-d. 
with the antibody specific to kinase domain 
residues 1142-l 153 and autoantibody B-10, but not 
with the antibody specific to the C-terminal 
residues 1327-1343 of the insulin receptor (not 
shown). The same trypsin treatment was conducted 
followed by two-dimensional phosphopeptide 
mapping. By this treatment, spots a, b and d were 
lost in two-dimensional phosphopeptide mapping 
(not shown) suggesting that these TPA phos- 
phorylated tryptic phosphopeptides were derived 
from the C-terminal region of the P-subunit. Con- 
sidering the data that protein kinase C phos- 
phorylates serine or threonine residues located 
close to basic residues at their N-terminal and/or 
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C-terminal side [ 10,13,14], we postulated Thr 1336 
and Ser 1340 in the C-terminal region to be the sites 
of phosphorylation by protein kinase C. The pep- 
tide coding residues 1327-l 343 was synthesized and 
phosphorylation attempted with protein kinase C 
and Ca’+ in the presence of PtS and OAG. Phos- 
phorylation of this peptide was increased 3.3-fold 
in the presence of PtS and OAG. Since the peptide 
coding residues 1327- 1343 contained one threonine 
and two serine residues, phosphoamino acid 
ptst-) PtS(+) 
OAGH OAG(+) 
**a*. 
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Fig.2. Phosphoamino acid analysis of protein kinase C- 
catalyzed synthetic C-terminal peptide in the rat insulin recep- 
tor. The rat insulin receptor synthetic peptide containing the C- 
terminal 17 residues was phosphorylated with Ca*+ and rat 
brain purified protein kinase C in the absence (1) and presence 
(2) of PtS and OAG as described in section. 2. An ambiguous 
spot shown close to phosphothreonine in the left panel was 
phosphorylated material which had migrated from another 
origin. 
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Fig.3. Peptide maps of protein kinase C-catalyzed synthetic C- 
terminal peptide and phosphorylated insulin receptor. Peptide 
maps of tryptic peptides derived from protein kinase C- 
catalyzed synthetic C-terminal peptide in the rat insulin receptor 
(l), &subunit of TPA-stimulated H-35 cell insulin receptor (2) 
and mixture (3) of the peptides shown in panels 1 and 2 are 
shown as autoradiograms. Origin of electrophoresis shown by 
the arrow. 
analysis was carried out. As shown in fig.2, only 
phosphothreonine was identified. Next, this phos- 
phopeptide was digested with TPCK-trypsin and 
separated by two-dimensional thin layer electro- 
phoresis and chromatography. The tryptic digest 
of the phosphopeptide coding residues 1327-l 343 
migrated to the same location of spot a in two- 
dimensional phosphopeptide mapping (fig.3). We 
concluded that both phosphopeptide 1327-1343 
and spot a contained the same tryptic phosphopep- 
tide. These results suggest that TPA phos- 
phorylates Thr 1336 in the human sequence of the 
rat insulin receptor &subunit by activating protein 
kinase C in an intact cell. 
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